SCHEMBL82497

SCHEMBL82497

CC(=O)N(C(C)C)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33
P2RX4 Q99571 2/20 0.32
P2RX1 P51575 1/20 0.32
P2RX3 P56373 1/20 0.32
P2RX7 Q99572 1/20 0.32
TP53 P04637 1/20 0.32
PIK3CD O00329 1/20 0.31
BCHE P06276 1/20 0.31
THPO P40225 1/20 0.31
FFAR3 O14843 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30682108 0.97 ALDH1A1 (0.32) TSHRALDH1A1TDP1LMNAP2RX4
Hydrochloric Acid SCHEMBL6491086 0.97 ALDH1A1 (0.32) TSHRALDH1A1TDP1LMNAP2RX4
SCHEMBL31602198 0.97 ALDH1A1 (0.32) TSHRALDH1A1TDP1LMNAP2RX4
SCHEMBL9305389 0.97 ALDH1A1 (0.32) TSHRALDH1A1TDP1LMNAP2RX4
SCHEMBL6070837 0.82 CHRM2 (0.33)
SCHEMBL6940471 0.80 FDPS (0.38)
SCHEMBL498404 0.78 ALDH1A1 (0.31) TSHRALDH1A1TDP1
SCHEMBL14184134 0.78
SCHEMBL624169 0.76 TP53 (0.37) TSHRALDH1A1TDP1LMNATP53
SCHEMBL11380541 0.76 TP53 (0.37) TSHRALDH1A1TDP1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177653-B2 PROCESS FOR MANUFACTURING ETHYLENE POLYMERS AND USING MODIFIERS EXXONMOBIL CHEMICAL PATENTS INC (US) 2026-01-21 EP claimed
CN-117957488-A Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element 日产化学株式会社 2024-04-30 CN claimed
US-20240067621-A1 POLYFLUORINATED CANNABINOID AND CANNABINOID-LIKE COMPOUNDS AND METHODS OF SYNTHESIS AND USE THEREOF WEAVER JIMMIE D (US) 2024-02-29 US claimed
EP-4298096-A1 POLYFLUORINATED DICYCLIC COMPOUNDS AND METHODS OF SYNTHESIS THEREOF The Board of Regents for the Oklahoma Agricultural And Mechanical Colleges (US) 2024-01-03 EP claimed
CN-114732916-B Targeted delivery of tertiary amine-containing drug substances 西雅图基因公司 2023-12-19 CN claimed
CN-116850801-A Polyamide separation membrane and preparation method and application thereof 天津科技大学 2023-10-10 CN claimed
WO-2023032753-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-03-09 WO claimed
EP-3131989-B1 LOW TOXICITY SOLVENT SYSTEM FOR POLYAMIDEIMIDE AND POLYAMIDE AMIC ACID RESIN COATING CYMER DAYTON LLC (US) 2022-11-09 EP claimed
WO-2022182623-A1 POLYFLUORINATED DICYCLIC COMPOUNDS AND METHODS OF SYNTHESIS THEREOF BOARD OF REGENTS FOR OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES (US) 2022-09-01 WO claimed
CN-114540024-A Perovskite quantum dot material with gas-sensitive property and application thereof 江苏烨湫传感科技有限公司 2022-05-27 CN claimed
EP-0461779-B1 Reaction accelerator for rearrangement of oxime to amide and process for producing amides by rearrangement of oximes IZUMI YUSUKE (JP) 1995-08-16 EP claimed
US-5254684-A In presence of phosphorus pentoxide and N,N-dialkyl amide, N-alkyl cyclic amide or dialkyl sulfoxide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-10-19 US claimed
US-5225547-A Using an alkylation reagent and disubstituted formamide or acid amide as promoters SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1993-07-06 US claimed
US-5224987-A Aqueous carriers with colors and tertiary amide penetrants E. I. DU PONT DE NEMOURS AND COMPANY (US) 1993-07-06 US claimed
EP-0515063-A1 Process for producing amide by liquid phase rearrangement of oxime SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1992-11-25 EP claimed
EP-0511940-A2 Phosphono/biaryl substituted dipeptide derivatives CIBA-GEIGY AG (CH) 1992-11-04 EP claimed
EP-0461779-A1 Reaction accelerator for rearrangement of oxime to amide and process for producing amides by rearrangement of oximes Izumi, Yusuke (JP) 1991-12-18 EP claimed
EP-0274795-B1 PROCESS FOR THE CARBONYLATION OF OLEFINICALLY UNSATURATED COMPOUNDS WITH A PALLADIUM CATALYST SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-08-21 EP claimed
US-4960926-A Process for the carbonylation of olefinically unsaturated compounds with a palladium catalyst SHELL OIL COMPANY (US) 1990-10-02 US claimed
US-4854973-A SHORT CHAIN CHLORINATED SOLVENTS NCH CORPORATION (US) 1989-08-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067621-A1 POLYFLUORINATED CANNABINOID AND CANNABINOID-LIKE COMPOUNDS AND METHODS OF SYNTHESIS AND USE THEREOF CNR2, CNR1, FAAH TSHR 3966/4885ALDH1A1 4183/4885TDP1 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.